Creating strong patents in Europe: How much data is needed & when by?
Sorry, this Event has now passed. However, there is a recording of the live event available by clicking here.
Presented by
Our People
News
- What can be patented in Biotechnology?
- Plant Variety Rights - an Alternative 'Root' of Protection
- Venner Shipley is now the preferred IP firm of the Oxbridge Biotech Roundtable (OBR)
- “Swiss” Claims Under the Microscope: AstraZeneca v Ranbaxy
- Brüstle v Greenpeace – The Patentability of Stem Cells in Europe
Downloads